Polyethylenimine-based micro/nanoparticles as vaccine adjuvants

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Vaccines require adjuvants to stimulate robust immune responses.
• Polyethylenimine (PEI), a cationic polymer, is recognized for its adjuvant potential.
• PEI's physicochemical properties and applications are well-documented.

Purpose of the Study:

• To review the properties and applications of PEI in vaccine development.
• To elaborate on the intracellular mechanisms of PEI-based vaccines.
• To summarize in vivo and clinical evidence of PEI's efficacy.

Main Methods:

• Literature review of physicochemical properties.
• Analysis of intracellular processes in PEI-based vaccines.
• Compilation of in vivo and clinical data.
• Exploration of immunoactivation mechanisms.

Main Results:

• PEI-based particles demonstrate significant adjuvant capabilities.
• Evidence supports PEI's in vivo and clinical effectiveness in vaccines.
• Intrinsic immunoactivation functions of PEI are highlighted.

Conclusions:

• PEI holds promise as a versatile adjuvant for vaccine applications.
• Understanding PEI's mechanisms can guide future vaccine design.
• Strategies exist to optimize PEI-based vaccine immunogenicity.